Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

Endo's CCH significantly improves cellulite in phase II study

Nov. 18, 2016

Janssen submits application to FDA seeking approval of guselkumab

Nov. 18, 2016

CHMP supports approval of AbbVie's Humira for adolescents with hidradenitis suppurativa

Nov. 15, 2016

Vallaurix presents MC1 receptor agonists

Nov. 15, 2016

Galectin Therapeutics looking for potential strategic partnership for GR-MD-02

Nov. 11, 2016

FDA clears IND for phase I/II trial of TWB-103 in split-thickness skin graft donor site wounds

Nov. 10, 2016

FDA approves Enbrel to treat children with moderate to severe plaque psoriasis

Nov. 7, 2016

Aclaris Therapeutics submits IND to begin study of ATI-50001

Nov. 4, 2016

MorphoSys and Leo Pharma collaborate to develop therapeutic antibodies in dermatology

Nov. 3, 2016

First-in-human dose administered in phase I clinical study of VB-1953

Nov. 2, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 15, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Rethinking anorexia: A disorder of mind and metabolism
BioWorld Science
Anorexia nervosa (AN) is a complex and severe eating disorder that has long been considered a psychiatric condition driven by distorted body image and maladaptive...